These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6977906)

  • 1. Influence of splenectomy upon immunologic reactivity of patients with Hodgkin's disease.
    Rogan-Grgas J; Milas L; Hauptmann E; Nola P; Kolarić K; Maricić Z; Malenica B
    Tumori; 1981 Dec; 67(6):539-47. PubMed ID: 6977906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
    Wagener DJ; Geestman E; Borgonjen A; Haanen C
    Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
    van Rijswijk RE; Sybesma JP; Kater L
    Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
    Pluzańska A
    Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.
    Loven D; Pick AI; Weiss H; Duczyminer-Kahana M; Lurie H
    Acta Oncol; 1991; 30(6):763-5. PubMed ID: 1958399
    [No Abstract]   [Full Text] [Related]  

  • 8. Ecotaxis: the principle and its application to the study of Hodgkin's disease.
    Sousa MD; Yang M; Lopes-Corrales E; Tan C; Hansen JA; Dupont B; Good RA
    Clin Exp Immunol; 1977 Jan; 27(1):143-51. PubMed ID: 300302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease.
    Schulof RS; Bockman RS; Garofalo JA; Cirrincione C; Cunningham-Rundles S; Fernandes G; Day NK; Pinsky CM; Incefy GS; Thaler HT; Good RA; Gupta S
    Cancer; 1981 Aug; 48(4):964-73. PubMed ID: 6456060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of splenectomy on the invitro lymphocyte response to phytohemagglutinin and pokeweed mitogen in Hodgkin's disease.
    Wagener DJ; Geestman E; Wessels HM
    Cancer; 1975 Jul; 36(1):194-8. PubMed ID: 1203846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing features of the immunology of Hodgkin's disease in children.
    Tan CT; De Sousa M; Good RA
    Cancer Treat Rep; 1982 Apr; 66(4):969-75. PubMed ID: 7074657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
    Bobrove AM; Fuks Z; Strober S; Kaplan HS
    Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical studies on the correlation between immunologic status and total gastrectomy combined with splenectomy.
    Takahashi M; Fujimoto S
    Jpn J Surg; 1980 Jun; 10(2):100-4. PubMed ID: 7431681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
    Björkholm M; Askergren J; Holm G; Mellstedt H
    Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
    Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
    Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
    Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
    Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-year survival in Hodgkin's disease. The prospective value of immune status at diagnosis.
    van Rijswijk RE; de Meijer A; Sybesma JP; Kater L
    Cancer; 1986 Apr; 57(8):1489-96. PubMed ID: 2936444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of cellular immune response by levamisole in patients with Hodgkin's disease.
    Levo Y; Rotter V; Ramot B
    Biomedicine; 1975 Jun; 23(6):198-200. PubMed ID: 1082352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the changes in the immune status before, during, and after multiple-agent chemotherapy for Hodgkin's disease.
    Van Rijswijk RE; Sybesma JP; Kater L
    Cancer; 1983 Feb; 51(4):637-44. PubMed ID: 6821837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B and T lymphocytes in Hodgkin's disease. Analysis at diagnosis and following therapy.
    Gajl-Peczalska KJ; Bloomfield CD; Sosin H; Kersey JH
    Clin Exp Immunol; 1976 Jan; 23(1):47-55. PubMed ID: 1083318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.